Qualitative interviews of patients with COPD and muscle weakness enrolled in a clinical trial evaluating a new anabolic treatment: patient perspectives of disease experience, trial participation and outcome assessments
Abstract Background Chronic obstructive pulmonary disease (COPD) and muscle weakness can cause impaired physical function, significantly impacting patients’ health-related quality of life (HRQoL). Loss of muscle strength is usually assessed through clinical and performance outcome (PerfO) assessment...
Main Authors: | Maggie Tabberer, Nicola Williamson, Sophi Tatlock, Adam Gater, Rebecca Grimes, Chika Akinseye, David Neil, Aoife Mahon-Smith, Linda Nelsen |
---|---|
Format: | Article |
Language: | English |
Published: |
SpringerOpen
2024-04-01
|
Series: | Journal of Patient-Reported Outcomes |
Subjects: | |
Online Access: | https://doi.org/10.1186/s41687-024-00712-0 |
Similar Items
-
Anabolic-androgenic steroids in sport
by: Martyna Dutka, et al.
Published: (2024-09-01) -
Newer anabolic therapies in osteopororsis
by: Monika Mittal, et al.
Published: (2012-01-01) -
Anabolic steroids in sport and exercise /
by: Yesalis, Charles E.
Published: (1993) -
A unique case of tachycardia‐mediated cardiomyopathy in a patient misusing anabolic steroids
by: Govinda Adhikari, et al.
Published: (2022-06-01) -
Multiple Small Bowel Intussusceptions in the Setting of Anabolic Steroid Use
by: Alex Davies, et al.
Published: (2024-01-01)